This SAMPS report describes what drug development and device companies think about CRO sales representatives.
How do buyers of drug development services and contract research organization (CRO) services view the vendors' representatives who call on them? How much do these representatives influence the awarding of a contract? From a buyer's perspective, what can sales representatives do better?
The SAMPS CRO Sales Representative Performance Survey details responses from 220 scientists, engineers, operations employees and procurement professionals in pharmaceutical, biotech, medical device and diagnostic companies. It was conducted by two highly respected leaders in life sciences marketing, Jon Meyer, co-founder and principal of Life Science Strategy Group, and Cinda Orr, president and CEO of SCORR Marketing.